Castor stent implantation combined with subclavian artery bypass grafting for the treatment of aortic arch lesions
- VernacularTitle:Castor支架联合颈锁转流治疗主动脉弓部病变
- Author:
Shuchun LI
1
;
Min JIN
1
;
Qing ZHOU
1
;
Dongjin WANG
1
Author Information
1. Department of Cardiac Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, P. R. China
- Publication Type:Journal Article
- Keywords:
Branched stent;
hybrid surgery;
thoracic endovascular aortic repair;
subclavian artery bypass grafting
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(12):1733-1737
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the short- and mid-term efficacy of Castor single branch aortic stent combined with subclavian artery bypass grafting for the aortic arch lesions. Methods A retrospective analysis of the clinical data of patients with proximal anchor zone insufficiency aortic arch lesions treated with Castor stent combined with subclavian artery bypass grafting at the Department of Cardiac Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School from August 2020 to November 2023 was performed. Results A total of 22 patients were included, including 19 males and 3 females, with an average age of (56±16) years. There were 18 patients of aortic dissection and 4 patients of aortic arch tumors. The success rate of surgical technique was 100.0%, and the average postoperative hospital stay for patients was (10±4) days. The median follow-up time was 20 months. During the follow-up period, there were no major complications such as endoleak, paraplegia, cerebral infarction, and renal insufficiency, and all patients had no readmissions. Conclusion For proximal anchor zone insufficiency aortic arch lesions, the treatment method of using a Castor stent branch placed in the left common carotid artery can effectively extend the anchor zone, avoid the huge trauma of open chest surgery, and achieve a good short- and mid-term efficacy.
